Definitive Contract HHSD200200929371C

This is a definitive, firm fixed-price contract awarded by the CDC Office of Acquisition Services, a civilian agency, to Glaxosmithkline Holdings (Americas) Inc. on April 1, 2009. The contract, valued at $13,015,897,209.20, is for the provision of pediatric vaccines under the Vaccines for Children (VFC) program. The contract has a period of performance through March 31, 2010 and does not have a set-aside designation. As the prime contractor, Glaxosmithkline Holdings (Americas) Inc. will be responsible for delivering the required pediatric vaccines to support the CDC's VFC program.